• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

African drugmaker Aspen bets on GLP-1 drugs to boost profit

cafead

Administrator
Staff member
  • cafead   Sep 03, 2024 at 06:12: PM
via
  • Aspen's FY core profit up 1%
  • Secures licence to commercialise GLP-1 drugs
  • Eli Lilly's Mounjaro could launch by year-end in S.Africa

article source
 

<